← All trials
NCT06270680
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2024
- Primary completion
- Dec 20, 2024
- Completion date
- Dec 20, 2024
- First posted
- Feb 21, 2024
- Last posted
- Mar 18, 2024
- Enrollment
- 52
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Pennsylvania State UniversityLead sponsor
- Orlando Regional Medical CenterCollaborator
- Pennsylvania State UniversityOfficial
- Pennsylvania State UniversitySponsor investigator
- MacuHealth LPCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.